* Sight Sciences Inc SGHT.OQ reported a quarterly adjusted
loss
of 22 cents per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -35 cents. The mean expectation of six analysts
for the quarter was for a loss of 32 cents per share. Wall
Street expected results to range from -44 cents to -20 cents per
share.
* Revenue fell 8.7% to $18.75 million from a year ago;
analysts
expected $18.95 million.
* Sight Sciences Inc's reported EPS for the quarter was a
loss
of 22 cents.
* The company reported a quarterly loss of $10.69 million.
* Sight Sciences Inc shares had fallen by 11.4% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 2.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Sight Sciences
Inc is $5.25
This summary was machine generated from LSEG data March 8 at
12:25 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.32 -0.22 Beat
Sep. 30 2023 -0.32 -0.27 Beat
Jun. 30 2023 -0.34 -0.30 Beat
Mar. 31 2023 -0.39 -0.35 Beat